h1

h2

h3

h4

h5
h6


001     567734
005     20250307110818.0
024 7 _ |2 HSB
|a eva23714
024 7 _ |2 ISSN
|a 0887-6924
024 7 _ |2 ISSN
|a 1476-5551
024 7 _ |2 SCOPUS
|a SCOPUS:2-s2.0-84951569512
024 7 _ |2 WOS
|a WOS:000366393900016
024 7 _ |2 doi
|a 10.1038/leu.2015.245
024 7 _ |2 pmid
|a pmid:26369986
037 _ _ |a RWTH-CONV-092106
041 _ _ |a English
100 1 _ |0 P:(DE-82)567866
|a Wenn, K.
|b 0
245 _ _ |a Telomere length at diagnosis of chronic phase chronic myeloid leukemia (CML-CP) identifies a subgroup with favourable prognostic parameters and molecular response according to the ELN criteria after 12 months of treatment with nilotinib
|h online, print
260 _ _ |a Basingstoke
|b Nature Publishing Group
|c 2015
336 7 _ |0 0
|2 EndNote
|a Journal Article
336 7 _ |0 PUB:(DE-HGF)16
|2 PUB:(DE-HGF)
|a Journal Article
|b journal
|m journal
336 7 _ |2 BibTeX
|a ARTICLE
336 7 _ |2 DRIVER
|a article
336 7 _ |2 DataCite
|a Output Types/Journal article
336 7 _ |2 ORCID
|a JOURNAL_ARTICLE
591 _ _ |a Germany
591 _ _ |a USA
700 1 _ |0 P:(DE-82)567867
|a Tomala, L.
|b 1
700 1 _ |0 P:(DE-82)080247
|a Wilop, S.
|b 2
700 1 _ |a Vankann, L.
|b 3
700 1 _ |0 P:(DE-82)097489
|a Hasenbank, C.
|b 4
700 1 _ |0 P:(DE-82)091918
|a Frank, O.
|b 5
700 1 _ |a Hochhaus, A.
|b 6
700 1 _ |a Giles, F. J.
|b 7
700 1 _ |a Lange, T.
|b 8
700 1 _ |a Müller, M. C.
|b 9
700 1 _ |0 P:(DE-82)IDM06178
|a Koschmieder, Steffen
|b 10
700 1 _ |a Beier, F.
|b 11
700 1 _ |0 P:(DE-82)IDM06069
|a Ziegler, Patrick
|b 12
700 1 _ |0 P:(DE-82)IDM06025
|a Brümmendorf, Tim Henrik
|b 13
|e Corresponding author
773 _ _ |0 PERI:(DE-600)2008023-2
|a 10.1038/leu.2015.245
|n 12
|p 2402-2404
|t Leukemia : normal and malignant hemopoiesis
|v 29
|x 0887-6924
909 C O |o oai:publications.rwth-aachen.de:567734
|p VDB
914 1 _ |y 2015
915 1 _ |0 StatID:(DE-HGF)0031
|2 StatID
|a Peer reviewed article
|x 0
915 _ _ |0 StatID:(DE-HGF)0100
|2 StatID
|a JCR
|b LEUKEMIA : 2014
915 _ _ |0 StatID:(DE-HGF)0110
|2 StatID
|a WoS
|b Science Citation Index
915 _ _ |0 StatID:(DE-HGF)0111
|2 StatID
|a WoS
|b Science Citation Index Expanded
915 _ _ |0 StatID:(DE-HGF)0150
|2 StatID
|a DBCoverage
|b Web of Science Core Collection
915 _ _ |0 StatID:(DE-HGF)0199
|2 StatID
|a DBCoverage
|b Thomson Reuters Master Journal List
915 _ _ |0 StatID:(DE-HGF)0200
|2 StatID
|a DBCoverage
|b SCOPUS
915 _ _ |0 StatID:(DE-HGF)0300
|2 StatID
|a DBCoverage
|b Medline
915 _ _ |0 StatID:(DE-HGF)0310
|2 StatID
|a DBCoverage
|b NCBI Molecular Biology Database
915 _ _ |0 StatID:(DE-HGF)1030
|2 StatID
|a DBCoverage
|b Current Contents - Life Sciences
915 _ _ |0 StatID:(DE-HGF)1050
|2 StatID
|a DBCoverage
|b BIOSIS Previews
915 _ _ |0 StatID:(DE-HGF)9910
|2 StatID
|a IF >= 10
|b LEUKEMIA : 2014
920 1 _ |0 I:(DE-82)521001-2_20140620
|k 521001-2
|l Lehrstuhl für Arbeitsmedizin
|x 0
920 1 _ |0 I:(DE-82)531040-2_20140620
|k 531040-2
|l Lehrstuhl für Innere Medizin (mit dem Schwerpunkt Onkologie und Hämatologie)
|x 1
970 _ _ |a eva23714
980 _ _ |a I:(DE-82)521001-2_20140620
980 _ _ |a I:(DE-82)531040-2_20140620
980 _ _ |a IMPORT
980 _ _ |a UNRESTRICTED
980 _ _ |a VDB
980 _ _ |a journal


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21